Find the latest pharmaceutical market place for formulations enquiry about Bevacizumab on PharmaCompass.com.

Tender// Bevacizumab (100 mg/ 4 ml) Solution for Injection needed in Poland [ENA18977]

Beskid Oncology Center - Municipal Hospital is looking for supplies of Bevacizumab (100 mg/ 4 ml) Solution for Injection for commercial purposes. The required quantity is 3,000 units. The deadline is 5-March-2024.

Reply

01 Feb 2024

Various Finished Dosage Formulations needed in Morocco [ENA17530]

A company that deals in the distribution of various finished formulations is looking for suppliers of Various Finished Dosage Formulations for commercial purposes.
1. L-asparaginase (10000 UI) Injections. The required quantity is 3,300 units.
2. Bevacizumab (100 mg & 400 mg) Injections. The required quantity is 4,110 units & 4,095 units.
3. Dacarbazine (200 mg) Injections. The required quantity is 8,890 units.
4. Melphalan (50 mg) Injections. The required quantity is 950 units.
5. Actinomycin-D (0.5 mg) Injections. The required quantity is 2,660 units.

Reply

12 Jul 2023

Various Finished Dosage Formulations needed in Brazil [ENA16235]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossier.
1. Pembrolizumab (100 mg) Injections
2. Paclitaxel (6 mg, 30 mg, 100 mg, 150 mg & 300 mg) Injections
3. Nivolumab (40 mg & 100 mg) Injections
4. Oxaliplatin (5 mg, 50 mg & 100 mg) Injections
5. Bevacizumab (25 mg) Injections

Reply

28 Jan 2023

Various Finished Dosage Formulations needed in Brazil [ENA12556]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossier, ANVISA, DMF & PIC/s GMP.
1. Infliximab (100 mg & 10 mg) Lyophilized Vials.
2. Bevacizumab (25 mg in 4 ml & 25 mg in 16 ml) Infusions.
3. Duloxetine HCl (60 mg & 30 mg) Slow release Capsules. The required quantity is 50 million units & 10 million units respectively.
4. Dabigatran (110 mg & 150 mg) Capsules. The required quantity is 28 million units & 10 million units respectively.

Reply

31 Jan 2022

Various Finished Dosage Formulations needed in Jordan [ENA11573]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each.
1. Methylprednisolone (250 mg) Vials. The required quantity is 55,000 units
2. Octreotide Acetate (20 mg) Vials. The required quantity is 6,000 units.
3. Octreotide (30 mg) Vials. The required quantity is 4,000 units.
4. Bevacizumab (100 mg) Vials. The required quantity is 32,000 units.
5. Peginterferon alfa 2a (180 mcg/ ml) Injections. The required quantity is 2,300 units.
6. Interferon Beta-1a (30 mcg) Vials. The required quantity is 16,000 units.

Reply

06 Oct 2021

United_States_of_America Flag

Various Finished Dosage Formulations needed in the United States [ENA11228]

A company that specializes in procuring and marketing pharmaceutical products, medical supplies, devices and equipment is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU certifications.
1. Acetylsalicylic Acid (325 mg) EC Tablets. The required quantity is 5,000 units.
2. Amlodipine (5 mg) Tablets. The required quantity is 10,000 units.
3. Anastrozole (1 mg) Tablets. The required quantity is 250 units.
4. Atorvastatin (10 mg & 20 mg) Tablets. The required quantity is 20,000 units & 10,000 units respectively.
5. Bevacizumab (100 mg & 400 mg) Injections. The required quantity is 40 units & 85 units respectively.
6. Bicalutamide (50 mg) Tablets. The required quantity is 200 units.
7. Carbimazole (20 mg & 5 mg) Tablets. The required quantity is 5,000 units each.
8. Carboplatin (150 mg) Injections. The required quantity is 50 units.
9. Carvedilol (12.5 mg & 25 mg) Tablets. The required quantity is 20,000 units each.
10. Cyclophosphamide (1000 mg) Injections. The required quantity is 100 units.

Reply

27 Aug 2021

Various Finished Dosage Formulations needed in Brazil [ENA10224]

A company that deals in the distribution of medical & surgical products is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this enquiry with ANVISA (optional).
1. Bevacizumab (400 mg/ 16 ml) Vials
2. Infliximab (100 mg) Powder for Solution
3. Adalimumab (40 mg/ 0.8 ml) Injections
4. Rituximab (500 mg/ 50 ml & 100 mg/ 10 ml) Injections
5. Cetuximab (5 mg/ ml in 100 ml) Injections

Reply

14 Apr 2021

Tender// Bevacizumab (100 mg/ 4 ml and 400 mg/ 16 ml) Vials needed in Belgium [ENA09718]

Chirec is looking for supplies of Bevacizumab (100 mg/ 4 ml and 400 mg/ 16 ml) Vials. The required quantity is 450 units and 600 units respectively. The suppliers must support this tender with ESPD. The deadline is 8-March-2021.

Reply

12 Feb 2021

Tender// Various Finished Dosage Formulations needed in Croatia [ENA09642]

Clinical Hospital Center Zagreb is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 8-March-2021.
1. Paclitaxel (5 mg/ ml) Solution for Infusion. The required quantity is 300 units.
2. Rituximab (1x100 mg/ 10 ml and 1x 500 mg/ 50 ml) Concentrate Solution for Infusion. The required quantity is 6 units and 400 units respectively.
3. Trastuzumab (1x150 mg) Solution for Injection. The required quantity is 100 units.
4. Bevacizumab (25 mg/ ml) Concentrate Solution for Infusion. The required quantity is 5 units and 1,500 units.
5. Daratumumab (1x1800 mg/ 15 ml) Solution for injection. The required quantity is 1,000 units.
6. Apalutamide (112 x 60 mg) Tablets. The required quantity is 56,448 units.
7. Durvalumab (50 mg/ ml) Concentrate solution for infusion. The required quantity is 100 units and 960 units.
8. Siponimod (12 x 0.25 mg) Tablets. The required quantity is 600 units and 5,280 units.
9. Siponimod (28 x 2 mg) Tablets. The required quantity is 600 units and 14,168 units.

Reply

03 Feb 2021

Tender// Various Finished Dosage Formulations needed by AZ Damiaan in Belgium [ENA09564]

AZ Damiaan is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 18-Feb-2021.
1. Bevacizumab (100 mg/ 4 ml and 400 mg/ 16 ml ) Injection. The required quantity is 3,600 units and 4,800 units respectively.
2. Fulvestrant (250 mg/ 5 ml) Injection. The required quantity is 3,600 units.
3. Azacitidine (100 mg) Injection. The required quantity is 2,250 units.

Reply

23 Jan 2021

Russia-big Flag

Tender// Bevacizumab Concentrate for Solution for Infusion needed in Russia [ENA09387]

State Autonomous Institution of Healthcare of Sverdlovsk Region “Sverdlovsk Regional Oncological Dispenser” is looking for supplies of Bevacizumab (25 mg/ ml in 4 ml & 16 ml Vial) Concentrate for Solution for Infusion. The required quantity is 1,000 pack and 1,500 pack respectively. The suppliers should comply with the requirements established in accordance with the legislation of the Russian Federation. The deadline is 19-Jan-2021.

Reply

31 Dec 2020

india-flag Flag

Various Finished Dosage Formulations needed in India [ENA07321]

RKD Pharmaceutical, a distributor company that deals in pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations. Interested suppliers can contact them via their email: rangan@rkdpharma.com.
1. Adalimumab 40 mg/0.8 ml Injection
2. Bevacizumab 400 mg/16 ml injection
3. Cetuximab 2 mg/ml Injection
4. Infliximab 100 mg Injection
5. Omalizumab 150 mg/ml Injection

Reply

18 May 2020

unitedkingdom_new Flag

Various Finished Formulations needed in the United Kingdom [ENA06585]

A company that specialises in the supply of various medical equipment such as MRI scanners, CT scanners, ultrasound machines, dialysis consumables is looking for suppliers of Various Finished Formulations:
1. Aflibercept 100 mg/4 ml (5 Units) & 200 mg/8 ml (5 Units) Vials
2. Bevacizumab 100 mg/4 ml (15 Units) & 400 mg/16 ml (15 Units) Vials
3. Bimatoprost 0.01% (1,000 Units), 0.3 mg/mL (1,000 Units) Ophthalmic Solution
4. Bimatoprost 0.3 mg/ml + Timolol 5 mg/ml (400 Units) Ophthalmic Solution
5. Brimonidine 0.15% w/v (1,000 Units) Ophthalmic Solution
6. Brimonidine 2 mg + Brinzolamide 10 mg (1000 Units) Ophthalmic Solution
7. Brimonidine Tartrate 2 mg + Timolol maleate 5 mg (3000 Units) Ophthalmic solution
8. Brinzolamide 1% w/v (1,000 Units) Ophthalmic Solution
9. Brinzolamide 10 mg + Timolol maleate 5 mg (1000 Units) Ophthalmic solution
10. Cyclopentolate Hydrochloride 0.5% (200 Units) & 1% (200 Units) Ophthalmic Solution
11. Epinastine Hydrochloride 0.5 mg/ ml (2,000 Units) Ophthalmic Solution
12. Fluorometholone 0.1 % w/v + Neomycin 0.35 % w/v (232 Units) Ophthalmic solution
13. Latanoprost 50 mcg (400 Units) + Timolol Maleate 6.8 mg (400 Units) Ophthalmic Solution
14. Latanoprost 50 mcg (2000 Units) Ophthalmic Solution
15. Levobunolol 0.5% (1,000 Units) Ophthalmic Solution
16. Moxifloxacin Hydrochloride 5.45 mg/ml (2,000 Units) Ophthalmic Solution
17. Nepafenac 1 mg (1,000 Units) & 3 mg (1,000 Units) Ophthalmic Solution
18. Ofloxacin 0.3% w/v (81 Units) Ophthalmic Solution
19. Olopatadine 1 mg/ml (2,000 Units) Ophthalmic Solution
20. Polyethylene Glycol 400 0.4% + Propylene Glycol 0.3% (1,000 Units) Ophthalmic Solution
21. Polyvinyl Alcohol 1.4% (5,000 Units) Ophthalmic Solution
22. Povidone 0.6% (5,000 Units) Ophthalmic Solution
23. Prednisolone Acetate (microfine suspension) 1% (1,000 Units) Ophthalmic Solution
24. Travoprost 40 mcg/ml + Timolol Maleate 5 mg/ml (400 Units) Ophthalmic Solution
25. Timolol 6.8 mg (400 Units) Ophthalmic Solution
26. Travoprost 0.004 % (2,000 Units) Ophthalmic Solution

Reply

15 Feb 2020